Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: Because of low mortality rates and high treatment-related adverse effects in patients diagnosed early, active surveillance, focused treatments, and watchful waiting are currently advocated, emphasizing the importance of proper prostate cancer (Pca) staging using imaging techniques. We aimed to comparatively investigate the success rates of multiparametric prostate magnetic resonance imaging (MRI) and prostate-specific membrane antigen (PSMA) positron emission tomography (PET)/MRI in predicting tumoral regions, seminal vesicle invasion, and extraprostatic extension.

Subjects And Methods: Twenty six patients with a biopsy diagnosis of prostate cancer who underwent radical prostatectomy between January 2021 and September 2022 were included in the study. Preoperative evaluation was conducted through a combination of multi-parametric (Mp)MR and PSMA PET/MRI. Findings such as tumoral regions, seminal vesicle invasion, and extra-prostatic extension in prostatectomy specimens were compared with the MpMRI and PSMA PET/MRI images.

Results: Prostate cancer was present in 103 foci of a total of 156 segments. In the context of identifying the aforementioned foci, the sensitivity of MpMRI was determined to be 74.8%, coupled with a specificity of 94.3%. Similarly, the sensitivity of PSMA PET/MRI was established at 70.9%, accompanied by a specificity rate of 90.6%. In the prediction of extraprostatic extension, MpMRI exhibited a sensitivity of 33.33% alongside a specificity of 78.57%. In contrast, PSMA PET/MRI displayed a sensitivity of 25% but achieved a higher specificity of 100%. Concerning the prediction of seminal vesicle invasion, MpMRI demonstrated a sensitivity of 40% and a specificity of 95.24%. Conversely, PSMA PET/MRI yielded a sensitivity of 60%, which was slightly superior to MpMRI's sensitivity with a close specificity rate of 95.24%.

Conclusion: MRI and PSMA PET/MRI are reliable methods for the local staging of prostate cancer and the prediction of tumor localization. No statistically significant advantage of either method was discerned in the course of our study.

Download full-text PDF

Source
http://dx.doi.org/10.1967/s002449912783DOI Listing

Publication Analysis

Top Keywords

psma pet/mri
24
prostate cancer
20
seminal vesicle
12
vesicle invasion
12
multiparametric prostate
8
pet/mri
8
radical prostatectomy
8
prostatectomy specimens
8
tumoral regions
8
regions seminal
8

Similar Publications

Background: This study aimed to evaluate the diagnostic performance of Ga-PSMA-11 PET/MRI in prostate cancer (PC) with biochemical recurrence (BCR) after radical prostatectomy (RP). It was also aimed to develop a nomogram to predict PET/MRI positivity.

Methods: The data of 140 PC patients who underwent Ga-PSMA-11 PET/MRI for BCR after RP were retrospectively analyzed.

View Article and Find Full Text PDF

Silicon-based ligands are of interest in increasingly used Prostate-specific membrane antigen (PSMA) tracers for prostate cancer (PCa) staging due to their simple and scalable production. Here, we present first data on dosimetry and biodistribution of the novel PSMA-specific tracer [¹⁸F]siPSMA-14.Seven PCa patients referred for PSMA-PET/CT imaging were imaged at 60 and 120 min p.

View Article and Find Full Text PDF

Predictive tumor dosimetry and pharmacokinetic evaluation of [Cu]Cu-rhPSMA-10.1 and [Ga]Ga-rhPSMA-10.1 with PET/SPECT MRI in an orthotopic mouse model of glioblastoma.

Nucl Med Biol

August 2025

PET Imaging Center, University Hospital North Norway, Hansine Hansens veg 82, 9019 Tromsø, Norway; Department of Medical Biology, Tumor Biology Research Group, UiT The Arctic University of Norway, Hansine Hansens veg 18, 9019 Tromsø, Norway. Electronic address:

Unlabelled: Targeted radionuclide therapy (TRT) is an emerging pillar of precision medicine, with prostate-specific membrane antigen (PSMA)-targeted agents like [Lu]PSMA-617 demonstrating notable clinical success. Achieving optimal therapeutic efficacy while minimizing toxicity requires precise tumor and organ dosimetry based on accurate time-activity curves (TACs) derived from molecular imaging. Glioblastoma (GBM), a highly treatment-resistant brain tumor with limited therapeutic possibilities, has shown PSMA expression, opening new avenues for TRT.

View Article and Find Full Text PDF

Objective: To assess the diagnostic value of fluorine 18 (18F)-labeled prostate-specific membrane antigen (PSMA)-1007 PET/MRI and compare with that of 18F-PSMA-1007 PET/computed tomography (CT) for biochemical recurrence (BCR) of prostate cancer (PCa) after radical prostatectomy.

Materials And Methods: We enrolled 40 patients who underwent 18F-PSMA-1007 PET/CT and 18F-PSMA-1007 PET/MRI for BCR after radical prostatectomy. Two readers independently assessed the images and determined their overall assessment of positive lesions on PET/MRI and PET/CT.

View Article and Find Full Text PDF

Comparative analysis of machine learning-derived nomogram and biomarkers in predicting side-specific extraprostatic extension: Preliminary findings.

Clin Imaging

September 2025

Advanced Molecular Imaging in Radiotherapy (AdMIRe) Research Laboratory, School of Health Sciences, Purdue University, West Lafayette, IN, United States of America; Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, IN, United States of America. Electronic address

Aim: This study aimed to assess and compare the performance of nomograms and machine learning (ML) techniques using preoperative biomarkers for predicting side-specific extraprostatic extension (EPE) in prostate cancer, which is linked to poor outcomes and early recurrence. Accurate preoperative prediction can guide clinical decisions and improve treatment.

Materials And Methods: A retrospective analysis was conducted using data from 108 prostate cancer patients undergoing radical prostatectomy.

View Article and Find Full Text PDF